Cost Recovery Implementation Statement (CRIS) - Regulation of medicinal cannabis 2021-22
Learn how cost recovery supports the regulation of Australia's Medicinal Cannabis Scheme, including fees, performance reporting and financial forecasts.
About this statement
The Cost Recovery Implementation Statement (CRIS) explains how the Department of Health implements cost recovery for regulatory activities associated with the Medicinal Cannabis Scheme.
The statement helps regulated entities understand how regulatory costs are recovered and how those arrangements support the administration of the medicinal cannabis framework.
Cost recovery arrangements
Cost recovery allows government agencies to recover some or all of the efficient costs associated with delivering regulatory services.
This may include:
- application fees
- annual charges
- other regulatory costs associated with administering the Medicinal Cannabis Scheme.
These arrangements support the regulation of medicinal cannabis activities under the Narcotic Drugs Act 1967.
Performance and financial reporting
The CRIS includes:
- financial performance information
- non-financial performance information
- details of cost recovery arrangements
- financial forecasts for 2020–21, 2021–22 and the following three financial years.
The Department maintains the statement while the cost recovery arrangements remain in place.